Loading…
Cross Country Healthcare Inc is projected to rise to $15.37 by 2027, a +16% move from its current price of $13.25. CCRN is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $13.12 | $13.26 | $13.40 | +0.08% |
| Aug 4 | $13.07 | $13.27 | $13.47 | +0.17% |
| Aug 5 | $13.04 | $13.28 | $13.53 | +0.25% |
| Aug 6 | $13.02 | $13.29 | $13.58 | +0.34% |
| Aug 7 | $12.99 | $13.31 | $13.62 | +0.42% |
| Aug 8 | $12.98 | $13.32 | $13.67 | +0.50% |
| Aug 9 | $12.96 | $13.33 | $13.71 | +0.59% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $12.96 | $13.33 | $13.71 | +0.59% |
| Week 2 | $12.89 | $13.41 | $13.95 | +1.18% |
| Week 3 | $12.85 | $13.49 | $14.16 | +1.78% |
| Week 4 | $12.83 | $13.57 | $14.35 | +2.38% |
| Week 5 | $12.82 | $13.65 | $14.53 | +2.98% |
| Week 6 | $12.82 | $13.73 | $14.70 | +3.59% |
| Week 7 | $12.82 | $13.81 | $14.87 | +4.20% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Cross Country Healthcare, Inc. provides talent management services for healthcare clients in the United States. The company operates in two segments: Nurse and Allied Staffing, and Physician Staffing.
This footprint covers staffing solutions for registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments, as well as physicians in various specialties on temporary assignments.
The company was founded in 1986 and is headquartered in Boca Raton, Florida.
Cross Country Healthcare, Inc. trades at $13.25 per share and has a market cap of $428.06M, ranking 3096.
The near-term technical picture shows bullish momentum with RSI14 at 80, and the price currently above the SMA50 of $13.10 and the SMA200 of $10.76.
Key support and resistance are at $13.17 and $13.25, respectively, with a 30-day range of $12.35 to $14.22.
The multi-year forecast points to a bullish price trajectory, with the 2026 average price at $13.25 rising to higher levels over time, including a 2040 average of $51.85 and a 2050 average of $106.82, accompanied by progressively larger ROIs up to 706.2% in 2050.
A major floor 30.7% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.6% away) — a key level to hold.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 0.4% above — clearing it would confirm fresh momentum.
Key CCRN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CCRN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $13.25 | Neutral | $13.25 | Buy |
| MA 10 | $13.25 | Buy | $13.24 | Buy |
| MA 20 | $13.23 | Buy | $13.22 | Buy |
| MA 50 | $13.18 | Buy | $12.83 | Buy |
| MA 100 | $11.67 | Buy | $12.08 | Buy |
| MA 200 | $10.76 | Buy | $11.75 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 75.26 | Sell |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 77.48 | Neutral |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | 0.23 | Buy |
| Bollinger %B (20,2) | 0.77 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.07 | Buy |
| Awesome (5,34) | 0.04 | Buy |
| Ultimate (7,14,28) | 95.49 | Sell |
| Momentum (10) | 0.03 | Buy |
| Aroon Osc (25) | 100.00 | Buy |
| Hull MA (9) | 13.25 | Sell |
| ADX (14) | 49.00 | Buy |
| ATR (14) | 0.01 | Info |
The 30-day technical picture remains bullish overall, with price momentum supported by a bullish sentiment and a strong RSI reading of 80.
The stock trades above the 50-day simple moving average of $13.10, with the 200-day moving average at $10.76 providing longer-term support. The framework shows immediate support at $13.17 and resistance at $13.25, placing the current price at the cusp of resistance.
The 30-day range spans from a low of $12.35 to a high of $14.22, indicating a tight near-term trading band around the current price.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $7.95 | $13.25 | $17.64 | 0% | Neutral | |
| $12.60 | $15.37 | $19.58 | +16% | Neutral | |
| $13.39 | $16.64 | $21.78 | +26% | Bullish | |
| $15.14 | $19.11 | $25.56 | +44% | Bullish | |
| $17.85 | $22.83 | $31.10 | +72% | Bullish | |
| $20.78 | $26.91 | $37.24 | +103% | Bullish | |
| $22.02 | $28.84 | $40.47 | +118% | Bullish | |
| $23.88 | $31.61 | $44.94 | +139% | Bullish | |
| $25.28 | $33.79 | $48.61 | +155% | Bullish | |
| $25.07 | $33.84 | $49.22 | +155% | Bullish | |
| $38.98 | $54.86 | $83.64 | +314% | Bullish | |
| $75.24 | $113.59 | $185.67 | +757% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $7.95 | $13.25 | $15.86 | +0.00% |
| September 2026 | $11.87 | $13.92 | $16.69 | +5.07% |
| October 2026 | $12.14 | $14.30 | $17.28 | +2.75% |
| November 2026 | $12.05 | $14.25 | $17.32 | -0.40% |
| December 2026 | $12.16 | $14.43 | $17.64 | +1.31% |
Click any year to see its month-by-month CCRN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect CCRN to range from $7.95 to $17.64 through 2026. The $13.25 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The CCRN price prediction for 2027 points to an average of $15.37 (low $12.60, high $19.58) — a potential gain of +16% on today's $13.25. Price action looks broadly range-bound.
In 2028, CCRN is projected to trade between $13.39 and $21.78, averaging $16.64 — a potential gain of +26% from today's $13.25. That is up +8% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Cross Country Healthcare Inc's 2029 outlook centres on $19.11, within a $15.14 to $25.56 range. That is up +15% on the projected 2028 average. That marks a +44% change versus current levels. Momentum favours further upside here.
By 2030, CCRN could reach as high as $31.10, with a base case around $22.83 and support toward $17.85 — roughly +72% from $13.25. Buyers look set to stay in control over this stretch.
Expect CCRN to range from $20.78 to $37.24 through 2031. The $26.91 average target implies a +103% move from current prices. That is up +18% on the projected 2030 average. Momentum favours further upside here.
The CCRN price prediction for 2032 points to an average of $28.84 (low $22.02, high $40.47) — a potential gain of +118% on today's $13.25. Buyers look set to stay in control over this stretch.
In 2033, CCRN is projected to trade between $23.88 and $44.94, averaging $31.61 — a potential gain of +139% from today's $13.25. That is up +10% on the projected 2032 average. Momentum favours further upside here.
Cross Country Healthcare Inc's 2034 outlook centres on $33.79, within a $25.28 to $48.61 range. That is up +7% on the projected 2033 average. That marks a +155% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, CCRN could reach as high as $49.22, with a base case around $33.84 and support toward $25.07 — roughly +155% from $13.25. Momentum favours further upside here.
Expect CCRN to range from $38.98 to $83.64 through 2040. The $54.86 average target implies a +314% move from current prices. That is up +62% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The CCRN price prediction for 2050 points to an average of $113.59 (low $75.24, high $185.67) — a potential gain of +757% on today's $13.25. Momentum favours further upside here.
Investing $1,000 in CCRN today (≈ 75.471698 CCRN) could be worth
$8,572.84
+$7,572.84 (+757%) by 2050 · US Dollar
Based on the average projected CCRN price of $113.59 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CCRNwould be worth at today's price.
$1,000 invested in CCRN on Jul 28, 2025 (≈ 72.411294 CCRN) would be worth
$959.45
-$40.55 (-4.1%) today · 0.96× · US Dollar
Based on a CCRN entry price of $13.81 vs. today's $13.25.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $13.25 | $1,000 | +0.0% |
| 1 month ago | $13.21 | $1,003.03 | +0.3% |
| 3 months ago | $10.27 | $1,290.17 | +29.0% |
| 6 months ago | $9.17 | $1,444.93 | +44.5% |
| 1 year ago | $13.81 | $959.45 | -4.1% |
| All time (5.0y) ago | $16.67 | $794.84 | -20.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CCRN forecast.
Our base-case forecast reaches $27.00 around 2032.
Implied market cap at $27.00: $872.28M
Looking out across the year-by-year forecast, the average price climbs from $13.25 in 2026 to $22.17 by 2030 and then to $51.85 in 2040, ending at $106.82 in 2050. The forecast maps a steady uptrend in the average price through 2035 at $32.56, then accelerating into the 2040s.
ROI expectations rise from 0% in 2026 to 14.8% in 2027, 23% in 2028, 42.7% in 2029, 67.3% in 2030, 95.6% in 2031, 112.2% in 2032, 129.4% in 2033, 143.4% in 2034, 145.7% in 2035, 291.3% in 2040, and 706.2% in 2050.
Sentiment shifts from Neutral in 2026 to Bullish from 2027 onward, reflecting an upward trajectory in price and investor expectations, albeit with the usual uncertainty and risk that accompanies forecasting over long horizons.
Tap a question to reveal the answer.
The forecasted average price for 2030 is $22.17, with a min of $17.33 and a max of $30.21; ROI is 67.3%.
The forecast shows a bullish path from 2027 onward, with rising average prices and positive ROIs (e.g., 14.8% in 2027, up to 706.2% by 2050). Note that 2026 is Neutral with 0% ROI, and these are estimates, not guarantees.
By 2050, the average price is forecast at $106.82 with a max of $174.62, suggesting a path that could exceed $100 in the long term, whereas 2040’s average is $51.85.
RSI14 is 80, indicating bullish momentum. The price is above the SMA50 of $13.10 and SMA200 of $10.76, with support at $13.17 and resistance at $13.25. The 30-day range is $12.35 to $14.22.
The current price is $13.25 and the market cap is $428.06M.
Cross Country Healthcare Inc Community Discussion
0Share your Cross Country Healthcare Inc price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.